» Articles » PMID: 29925040

Cellular Trajectories and Molecular Mechanisms of IPSC Reprogramming

Overview
Publisher Elsevier
Specialties Biology
Genetics
Date 2018 Jun 21
PMID 29925040
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

The discovery of induced pluripotent stem cells (iPSCs) has solidified the concept of transcription factors as major players in controlling cell identity and provided a tractable tool to study how somatic cell identity can be dismantled and pluripotency established. A number of landmark studies have established hallmarks and roadmaps of iPSC formation by describing relative kinetics of transcriptional, protein and epigenetic changes, including alterations in DNA methylation and histone modifications. Recently, technological advancements such as single-cell analyses, high-resolution genome-wide chromatin assays and more efficient reprogramming systems have been used to challenge and refine our understanding of the reprogramming process. Here, we will outline novel insights into the molecular mechanisms underlying iPSC formation, focusing on how the core reprogramming factors OCT4, KLF4, SOX2 and MYC (OKSM) drive changes in gene expression, chromatin state and 3D genome topology. In addition, we will discuss unexpected consequences of reprogramming factor expression in in vitro and in vivo systems that may point towards new applications of iPSC technology.

Citing Articles

The miR-290 and miR-302 clusters are essential for reprogramming of fibroblasts to induced pluripotent stem cells.

Ye J, Boileau R, Parchem R, Judson-Torres R, Blelloch R Stem Cells. 2025; 43(2).

PMID: 40037390 PMC: 11879289. DOI: 10.1093/stmcls/sxae080.


The miR-290 and miR-302 clusters are essential for reprogramming of fibroblasts to induced pluripotent stem cells.

Ye J, Boileau R, Parchem R, Judson-Torres R, Blelloch R bioRxiv. 2024; .

PMID: 39282363 PMC: 11398367. DOI: 10.1101/2024.09.02.610895.


From iPSCs to Pancreatic β Cells: Unveiling Molecular Pathways and Enhancements with Vitamin C and Retinoic Acid in Diabetes Research.

Arroyave F, Uscategui Y, Lizcano F Int J Mol Sci. 2024; 25(17).

PMID: 39273600 PMC: 11395045. DOI: 10.3390/ijms25179654.


Early inhibition of BRD4 facilitates iPSC reprogramming via accelerating rDNA dynamic expression.

Zhang Z, Hu X, Sun Y, Lei L, Liu Z BMC Biol. 2024; 22(1):195.

PMID: 39256730 PMC: 11389306. DOI: 10.1186/s12915-024-01997-9.


The hope, hype and obstacles surrounding cell therapy.

Treda C, Wlodarczyk A, Rieske P J Cell Mol Med. 2024; 28(10):e18359.

PMID: 38770886 PMC: 11107145. DOI: 10.1111/jcmm.18359.


References
1.
Nakajima-Koyama M, Lee J, Ohta S, Yamamoto T, Nishida E . Induction of Pluripotency in Astrocytes through a Neural Stem Cell-like State. J Biol Chem. 2015; 290(52):31173-88. PMC: 4692240. DOI: 10.1074/jbc.M115.683466. View

2.
Chen J, Liu H, Liu J, Qi J, Wei B, Yang J . H3K9 methylation is a barrier during somatic cell reprogramming into iPSCs. Nat Genet. 2012; 45(1):34-42. DOI: 10.1038/ng.2491. View

3.
Beagan J, Gilgenast T, Kim J, Plona Z, Norton H, Hu G . Local Genome Topology Can Exhibit an Incompletely Rewired 3D-Folding State during Somatic Cell Reprogramming. Cell Stem Cell. 2016; 18(5):611-24. PMC: 4859942. DOI: 10.1016/j.stem.2016.04.004. View

4.
Narayan S, Bryant G, Shah S, Berrozpe G, Ptashne M . OCT4 and SOX2 Work as Transcriptional Activators in Reprogramming Human Fibroblasts. Cell Rep. 2017; 20(7):1585-1596. PMC: 5648000. DOI: 10.1016/j.celrep.2017.07.071. View

5.
Hanna J, Saha K, Pando B, van Zon J, Lengner C, Creyghton M . Direct cell reprogramming is a stochastic process amenable to acceleration. Nature. 2009; 462(7273):595-601. PMC: 2789972. DOI: 10.1038/nature08592. View